"Tech Prophet" Who Predicted the iPhone Now Predicts...

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Popular

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.

Why Are 21 Billionaires Moving Their Money ASAP? - Ad

One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.

Why Is Scholar Rock Holding Stock Climbing Today?

Scholar Rock shares jump after the company strengthened its cash runway into 2027 and advanced launch preparations for its lead drug candidate, apitegromab.

Some Social Security Recipients Won't Have To Wait Until 2026 For COLA Hike

Social Security and SSI recipients will receive a 2.8% cost-of-living adjustment in 2026, with SSI beneficiaries seeing the increase a day earlier due to a federal holiday.

Forget Amazon's 1997 IPO... This Could Be 287 Times Bigger - Ad

Since Amazon's IPO in 1997, it climbed enough to turn $100 into $250,000. Now, one man says Elon Musk could be gearing up to take his internet satellite giant public... in what Fortune magazine says will be the biggest IPO in history! James Altucher is sharing how ANYONE can get a pre-IPO stake... with as little as $100!

FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths

WASHINGTON (AP) — The Food and Drug Administration said Friday it will add a new warning and other limitations to a that's been linked to .

Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus

Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.

The Next Biggest Bull Run In Over 50 Years - Ad

Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain

Applied Therapeutics stock falls after FDA feedback prompts another Type C meeting to discuss the Phase 3 plan for its CMT-SORD drug govorestat.

Workers take on side jobs to combat stagnant salaries and insecurity about employment

NEW YORK (AP) — As workers face , inflation and , some have decided to branch out from their traditional careers. They're taking on side jobs to bring in additional income and provide a backup plan should they , or adding second, third and sometimes fourth jobs — what some call “polyworking” — to the mix.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.

2 new malaria treatments announced as drug resistance grows

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs.

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.

The AI Arms Race Could Send This Obscure Firm Soaring - Ad

The AI arms race could be a massive boom to ONE company that's doing something truly unprecedented. Its new device could become the cornerstone of the next wave of the AI revolution... And early investors could make a substantial sum of money as this story hits the mainstream.

House returns for vote to end the government shutdown after nearly 2 months away

WASHINGTON (AP) — House lawmakers will make a long-awaited return to the nation's capital on Wednesday after nearly eight weeks away to potentially put an end to the longest in U.S. history.

FDA names longtime cancer scientist Pazdur to lead drug center

WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to lead the agency's drug center, replacing the who was recently ousted after an .

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial

AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in resistant hypertension patients.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

Landmark Paris Agreement set a path to slow warming. The world hasn't stayed on it

The world has changed dramatically in the decade since leaders celebrated a a decade ago, but not quite in ways they expected or wanted.

Embed-Chart-Protecting Miners, ADVISORY

PROTECTING MINERS — Chart. This AP digital embed chart shows the percentage of longterm coal miners since 1974 tested for black lung disease who were found to have the ailment. After two decades of declines, the numbers have risen again, most prominently among miners in the central Appalachian region that includes Kentucky, Virginia and West Virginia. This chart is current as of Nov. 3, 2025, and will not update. Source: NIOSH Coal Workers’ Health Surveillance Program.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal

Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and Interventional segments despite China headwinds.

FDA warns websites selling unapproved Botox for cosmetic purposes

Associated Press (AP) — U.S. health regulators on Wednesday sent warning letters to 18 websites selling and similar injectable drugs commonly used to smooth wrinkles.

Jensen Huang's Secret Masterplan Revealed - Ad

NVIDIA's revolutionary new invention just solved the #1 chokepoint that's been strangling big AI companies. And Tech legend Jeff Brown - the Silicon Valley insider who called NVIDIA before it skyrocketed more than 30,000%... says a shocking announcement by NVIDIA CEO Jensen Huang could make a lot of early investors rich.

Zoetis Stock Outlook Clouded By Rising Competitive Pressures

Zoetis tops Q3 earnings estimates but trims 2025 sales forecast as companion animal growth slows and competition weighs on its outlook.

First clinical trial of pig kidney transplants gets underway

WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting might really save lives.

Nvidia CEO: E.I. Will Be as Common as Cars Today - Ad

E.I. isn't science fiction anymore. It's already here. And one little-known company is quietly supplying the systems behind it. This stock is still under Wall Street's radar... but not for long. You'll get the name, the ticker, and the full thesis inside.

UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data

UniQure shares fell after the FDA questioned the adequacy of data supporting its AMT-130 gene therapy for Huntington's disease, delaying BLA plans.

Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?

Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE: KVUE).

Why Are 21 Billionaires Moving Their Money ASAP? - Ad

One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.

Super greens powder supplements sold at Sam's Club linked to salmonella outbreak

At least 11 people have been sickened, including three who were hospitalized, with linked to sold at nationwide and online, federal health officials said Friday.

Forget Amazon's 1997 IPO... This Could Be 287 Times Bigger - Ad

Since Amazon's IPO in 1997, it climbed enough to turn $100 into $250,000. Now, one man says Elon Musk could be gearing up to take his internet satellite giant public... in what Fortune magazine says will be the biggest IPO in history! James Altucher is sharing how ANYONE can get a pre-IPO stake... with as little as $100!

Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

Federal health officials push effort to spur cheaper biotech drugs

Federal regulators are trying to make it easier to develop to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service